The 20 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 40.50, with a high estimate of 75.00 and a low estimate of 32.00. The median estimate represents a +19.47% increase from the last price of 33.90.
The current consensus among 26 polled investment analysts is to Hold stock in Pfizer Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.71
Reporting Date Oct 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.